title: Beta blocker treatment of infantile conjunctival hemangiomas--observations from 2 cases.
abstract: Infantile conjunctival hemangiomas are rare lesions in comparison to cutaneous and orbital capillary hemangiomas. They generally present several weeks following birth as a red stromal mass. Recent reports of cutaneous and orbital infantile hemangiomas involuting in response to oral or topical beta blocker treatment suggest that infantile conjunctival hemangiomas could respond similarly. We report 2 cases of presumed infantile hemangiomas of the conjunctiva. One, associated with cutaneous hemangiomas, did not respond to oral propranolol; the other was isolated and resolved with topical timolol.
authors.affiliation: Bascom Palmer Eye Institute, University of Miami, School of Medicine, Miami, Florida. Electronic address: t.chang@med.miami.edu.
authors.forename: Ta C
authors.initials: TC
authors.lastname: Chang
authors.affiliation: Vanderbilt Eye Institute, Vanderbilt University School of Medicine, Nashville, Tennessee.
authors.forename: Robert
authors.initials: R
authors.lastname: Estes
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D003230:Conjunctival Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006391:Hemangioma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007223:Infant; D011433:Propranolol / Q000627:therapeutic use*; D013999:Timolol / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D013999:Timolol; D011433:Propranolol